Over the past few years, inexpensive data storage coupled with advancements in supercomputers and artificial intelligence (AI) analytics have allowed the exploitation of population data in ways that megalomaniac technocrats and totalitarian dictators could only have dreamed of just a decade or two ago.
US government advisers in March said that Chinese firm BGI Group was constructing a vast bank of genomic data that, combined with AI tools, would allow China to monopolize the global pharmaceutical industry, “build” genetically enhanced soldiers and — most concerning of all — engineer pathogens to empower ethnically targeted bioweapons.
Reuters on Wednesday published a special report on BGI Group’s gene harvesting that makes for chilling reading.
BGI Group’s prenatal test, branded NIFTY (Non-Invasive Fetal TrisomY) is one of the most popular in the world and has been used to harvest genetic data from millions of women in at least 52 countries, the report says. The company reportedly stores and reanalyzes leftover blood samples and genetic data from the tests — taken by more than 8 million women around the world — to detect abnormalities such as Down syndrome in fetuses.
A review of scientific papers and company statements by Reuters found that the tests capture genetic information about the mother, which is what appears to be of interest to the Chinese military.
The report says that BGI Group has collaborated with the Chinese People’s Liberation Army (PLA) on at least a dozen studies since 2010, including conducting research into population traits. One such study used a PLA military supercomputer to reanalyze gene data collected from NIFTY tests to isolate specific character traits in Tibetan and Uighur minorities.
The Reuters investigation found that genomic data collected by BGI Group from women outside of China have been stored in a gene database funded by the Chinese government.
While some of the studies could have benign medical uses — such as tracking the effect of hepatitis B on different ethnicities to develop enhanced antiviral treatments — the PLA’s involvement should be a red flag, especially given China’s openly stated doctrine of “civil-military fusion.”
The PLA could use the vast database to find genetic vulnerabilities in a population — perhaps an adversary nation. A particular susceptibility to disease could be identified and then targeted with a genetically tailored bioweapon. The collaboration of civilian and PLA scientists on “gain of function” coronavirus experiments at the Wuhan Institute of Virology is well-documented.
China is known to have initiated a biowarfare research program in the early 1950s. In 1984, Beijing signed the Biological Weapons Convention, a disarmament treaty prohibiting signatory nations from developing, acquiring or stockpiling biological and toxin weapons, but the US intelligence community regardless continues to be concerned about PLA research on bioweapons.
A senior US Department of State official, speaking anonymously to China analyst and author Bill Gertz last year, said that classified Chinese research on biological warfare includes engineered weapons designed to attack specific ethnic groups with pathogens.
“We are looking at potential biological experiments on ethnic minorities,” the source said.
BGI Group’s collaboration with the PLA could be the tip of the iceberg. Who knows if other Chinese companies are also harvesting gene data from around the world?
Taiwan and other nations must take the threat seriously and direct resources to discovering whatever they can about the capabilities and intent of what appears to be a covert Chinese bioweapons program — before it is too late.
From the Iran war and nuclear weapons to tariffs and artificial intelligence, the agenda for this week’s Beijing summit between US President Donald Trump and Chinese President Xi Jinping (習近平) is packed. Xi would almost certainly bring up Taiwan, if only to demonstrate his inflexibility on the matter. However, no one needs to meet with Xi face-to-face to understand his stance. A visit to the National Museum of China in Beijing — in particular, the “Road to Rejuvenation” exhibition, which chronicles the rise and rule of the Chinese Communist Party — might be even more revealing. Xi took the members
The Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP) on Friday used their legislative majority to push their version of a special defense budget bill to fund the purchase of US military equipment, with the combined spending capped at NT$780 billion (US$24.78 billion). The bill, which fell short of the Executive Yuan’s NT$1.25 trillion request, was passed by a 59-0 margin with 48 abstentions in the 113-seat legislature. KMT Chairwoman Cheng Li-wun (鄭麗文), who reportedly met with TPP Chairman Huang Kuo-chang (黃國昌) for a private meeting before holding a joint post-vote news conference, was said to have mobilized her
The inter-Korean relationship, long defined by national division, offers the clearest mirror within East Asia for cross-strait relations. Yet even there, reunification language is breaking down. The South Korean government disclosed on Wednesday last week that North Korea’s constitutional revision in March had deleted references to reunification and added a territorial clause defining its border with South Korea. South Korea is also seriously debating whether national reunification with North Korea is still necessary. On April 27, South Korean President Lee Jae-myung marked the eighth anniversary of the Panmunjom Declaration, the 2018 inter-Korean agreement in which the two Koreas pledged to
As artificial intelligence (AI) becomes increasingly widespread in workplaces, some people stand to benefit from the technology while others face lower wages and fewer job opportunities. However, from a longer-term perspective, as AI is applied more extensively to business operations, the personnel issue is not just about changes in job opportunities, but also about a structural mismatch between skills and demand. This is precisely the most pressing issue in the current labor market. Tai Wei-chun (戴偉峻), director-general of the Institute of Artificial Intelligence Innovation at the Institute for Information Industry, said in a recent interview with the Chinese-language Liberty Times